TPG Group Holdings (SBS) Advisors’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-13,240,462
| Closed | -$11.4M | – | 46 |
|
|
2019
Q4 | $11.4M | Hold |
13,240,462
| – | – | 0.17% | 37 |
|
|
2019
Q3 | $7.42M | Hold |
13,240,462
| – | – | 0.11% | 45 |
|
|
2019
Q2 | $6.88M | Sell |
13,240,462
-1,000,000
| -7% | -$499K | 0.1% | 43 |
|
|
2019
Q1 | $6.41M | Hold |
14,240,462
| – | – | 0.13% | 45 |
|
|
2018
Q4 | $6.83M | Hold |
14,240,462
| – | – | 0.11% | 48 |
|
|
2018
Q3 | $7.55M | Hold |
14,240,462
| – | – | 0.1% | 52 |
|
|
2018
Q2 | $7.12M | Hold |
14,240,462
| – | – | 0.09% | 50 |
|
|
2018
Q1 | $6.02M | Hold |
14,240,462
| – | – | 0.09% | 43 |
|
|
2017
Q4 | $5.41M | Hold |
14,240,462
| – | – | 0.08% | 41 |
|
|
2017
Q3 | $5.13M | Hold |
14,240,462
| – | – | 0.08% | 40 |
|
|
2017
Q2 | $5.41M | Hold |
14,240,462
| – | – | 0.07% | 42 |
|
|
2017
Q1 | $6.41M | Sell |
14,240,462
-180,000
| -1% | -$79.1K | 0.08% | 46 |
|
|
2016
Q4 | $5.48M | Sell |
14,420,462
-5,820,000
| -29% | -$1.97M | 0.06% | 47 |
|
|
2016
Q3 | $5.46M | Hold |
20,240,462
| – | – | 0.06% | 48 |
|
|
2016
Q2 | $4.86M | Buy |
+20,240,462
| New | +$3.48M | 0.05% | 49 |
|
TPG Group Holdings (SBS) Advisors's GCVRZ Position: Q1 2020 in Review
TPG Group Holdings (SBS) Advisors sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 13,240,462 shares — an estimated $11.4M sold.
TPG Group Holdings (SBS) Advisors first reported a position in GCVRZ in Q2 2016 and held it in 15 quarters. The position peaked at $11.4M in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- TPG Group Holdings (SBS) Advisors reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- TPG Group Holdings (SBS) Advisors sold 13,240,462 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $11.4M.
- TPG Group Holdings (SBS) Advisors first reported a position in Sanofi Contingent Value Rights in Q2 2016 and held it in 15 quarters.
- TPG Group Holdings (SBS) Advisors's Sanofi Contingent Value Rights position peaked at $11.4M in Q4 2019.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on TPG Group Holdings (SBS) Advisors's 13F filing for Q1 2020, filed 15 May 2020.